Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Cortney Caudill

COO at Halozyme Therapeutics, Inc. (HALO)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.2M

Reported trades

Filed Stock Type Shares Price Value Since
Mar 10SEC HALOHalozyme Therapeutics, Inc. Sell 17,90016,466 held (−52%) $67.75 $1.2M +79.8%
Mar 10SEC HALOHalozyme Therapeutics, Inc. Sell 2,10014,366 held (−13%) $68.25 $143K +78.5%
Mar 10SEC HALOHalozyme Therapeutics, Inc. Sell 8,8577,055 held (−56%) $67.64 $599K +80.1%
Dec 19SEC HALOHalozyme Therapeutics, Inc. Sell 4,26312,737 held (−25%) $65.19 $278K +86.9%
  • Sell

    COO Cortney Caudill sold $1.2M of HALO at $67.75 — cuts the stake by 52%.

  • Sell

    COO Cortney Caudill sold $599K of HALO at $67.64 — cuts the stake by 56%.

  • Sell

    COO Cortney Caudill sold $278K of HALO at $65.19 — cuts the stake by 25%.